{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:33:49Z","timestamp":1787002429927,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1126,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/jid.2012.179","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T08:27:43Z","timestamp":1340267263000},"page":"2652-2660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["NFATc2 Is a Potential Therapeutic Target in Human Melanoma"],"prefix":"10.1016","volume":"132","author":[{"given":"Valentina","family":"Perotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Baldassari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vegetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Dal","family":"Col","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Anichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mortarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.179_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002329900155","article-title":"Ion channels phenotype of human melanoma cells","volume":"155","author":"Allen","year":"1997","journal-title":"J Membr Biol"},{"key":"10.1038\/jid.2012.179_bb0015","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1158\/0008-5472.CAN-06-0854","article-title":"Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients","volume":"66","author":"Anichini","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.179_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bcp.2006.12.001","article-title":"The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events","volume":"73","author":"Caballero","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/jid.2012.179_bb0025","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with Vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2012.179_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijc.21153","article-title":"Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies","volume":"117","author":"Ciechomska","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.179_bb0035","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1038\/sj.onc.1207780","article-title":"BRAF alterations are associated with complex mutational profiles in malignant melanoma","volume":"23","author":"Daniotti","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/jid.2012.179_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.22621","article-title":"Functional genomics of calcium channels in human melanoma cells","volume":"121","author":"Deli","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.179_bb0045","first-page":"782","article-title":"Cyclosporin A inhibits calcineurin\/nuclear factor of activated T- cells signaling and induces apoptosis in retinoblastoma cells","volume":"46","author":"Eckstein","year":"2005","journal-title":"IOVS"},{"key":"10.1038\/jid.2012.179_bb0050","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1200\/JCO.2002.07.044","article-title":"Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial","volume":"20","author":"Eton","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2012.179_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1081\/CNV-46368","article-title":"Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma","volume":"23","author":"Feun","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1038\/jid.2012.179_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","article-title":"Systematic review of medical treatment in melanoma: current status and future prospects","volume":"16","author":"Garbe","year":"2011","journal-title":"The Oncologist"},{"key":"10.1038\/jid.2012.179_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ccr.2010.04.025","article-title":"Wnt\/Ca2+\/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl","volume":"18","author":"Gregory","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1038\/jid.2012.179_bb0070","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/onc.2009.428","article-title":"Caspase 2-mediated tumor suppression involves survivin gene silencing","volume":"29","author":"Guha","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/jid.2012.179_bb0075","first-page":"1053","article-title":"Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells","volume":"23","author":"Han","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1038\/jid.2012.179_bb0080","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/jid.2008.226","article-title":"Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside","volume":"128","author":"Hocker","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.179_bb0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood.V91.3.1001","article-title":"Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells","volume":"91","author":"Ito","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2012.179_bb0090","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/j.gastro.2009.10.045","article-title":"NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells","volume":"138","author":"K\u00f6enig","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1038\/jid.2012.179_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc2745","article-title":"Caspase 2 in apoptosis, the DNA damage response and tumor suppression: enigma no more?","volume":"9","author":"Kumar","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/jid.2012.179_bb0100","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.bjc.6605277","article-title":"NFAT signaling is a novel target of oncogenic BRAF in metastatic melanoma","volume":"101","author":"Lockart","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1038\/jid.2012.179_bb0105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.bjc.6604927","article-title":"Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation","volume":"100","author":"Lopergolo","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1038\/jid.2012.179_bb0110","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/MCB.16.7.3955","article-title":"Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes","volume":"16","author":"Luo","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1038\/jid.2012.179_bb0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrc2735","article-title":"NFAT proteins: emerging roles in cancer progression","volume":"9","author":"Mancini","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/jid.2012.179_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncponc0140","article-title":"Mechanisms of disease: inflammatory mediators and cancer prevention","volume":"2","author":"Mann","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/jid.2012.179_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.200811105","article-title":"Caspase-2 activation in the absence of PIDDosome formation","volume":"185","author":"Manzl","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2012.179_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cc.7.3.5357","article-title":"The calcineurin\/NFAT signaling pathway. A novel therapeutic target in leukemia and solid tumors","volume":"7","author":"Medyouf","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1038\/jid.2012.179_bb0135","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-08-3323","article-title":"Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage","volume":"15","author":"Mortarini","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2012.179_bb0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4049\/jimmunol.123.1.342","article-title":"Use of monoclonal antibody (W6\/32) in structural studies of HLA-A, -B, -C antigens","volume":"123","author":"Parham","year":"1979","journal-title":"J Immunol"},{"key":"10.1038\/jid.2012.179_bb0145","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-05-4671","article-title":"Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity","volume":"66","author":"Petti","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.179_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.01.008","article-title":"Mutant BRAF melanomas-dependence and resistance","volume":"19","author":"Poulikakos","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1038\/jid.2012.179_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/01.RES.0000069211.82346.46","article-title":"NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro","volume":"92","author":"Pu","year":"2003","journal-title":"Circ Res"},{"key":"10.1038\/jid.2012.179_bb0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1073\/pnas.0408744102","article-title":"The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development","volume":"102","author":"Ren","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.179_bb0165","first-page":"2129","article-title":"Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway","volume":"31","author":"Sato","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1038\/jid.2012.179_bb0170","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/sj.onc.1209379","article-title":"Mutually exclusive NRASQ61R and BRAFV600E mutations at the single cell level in the same human melanoma","volume":"25","author":"Sensi","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/jid.2012.179_bb0175","doi-asserted-by":"crossref","first-page":"27241","DOI":"10.1074\/jbc.M110.100438","article-title":"Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-\u03b2 switch from a suppressor to a promoter of cancer cell proliferation","volume":"285","author":"Singh","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.179_bb0180","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/cdd.2011.34","article-title":"Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21WAF1\/CIP1","volume":"18","author":"Sohn","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1038\/jid.2012.179_bb0185","doi-asserted-by":"crossref","first-page":"40050","DOI":"10.1074\/jbc.M110.154955","article-title":"Calcineurin signaling regulates human islet \u03b2-cell survival","volume":"285","author":"Soleimanpour","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.179_bb0190","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1084\/jem.20072484","article-title":"The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis","volume":"205","author":"Weigmann","year":"2008","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2012.179_bb0195","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1074\/jbc.M511759200","article-title":"Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3","volume":"281","author":"Wu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.179_bb0200","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1158\/0008-5472.CAN-04-1640","article-title":"Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents","volume":"64","author":"Zanon","year":"2004","journal-title":"Cancer Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:42:35Z","timestamp":1743946955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15355263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022202X15355263"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.179","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NFATc2 Is a Potential Therapeutic Target in Human Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}